Effectiveness of a 12-week self-myofascial release therapy on pain and tendon stiffness in active recreational runners with self-reported Achilles tendon complaints

Effectiveness of a 12-week self-myofascial release therapy on pain and tendon stiffness in active recreational runners with self-reported Achilles tendon complaints - SMR in active recreational runners with achilles tendon complaints

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44629

Enrollment

Registered

2017-11-03

Start date

2018-01-25

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles tendon complaints (pain stiffness)

Interventions

All subjects will be instructed on how to perform the exercises by instructional videos and written protocols. The exercises (SMR or ECC) are to be carried out 7 days a week for 12 weeks, twice a da

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: active recreational runners older than 18 years, self-reported achilles tendon complaints (pain, stiffness)

Exclusion criteria

Exclusion criteria: (1) presence of severe cardiovascular, neurologic, endocrine, psychiatric, or orthopaedic diseases (except Achilles tendinopathy); (2) simultaneous participation in other studies; (3) pregnancy or nursing period; (4) regular intake of analgesic drugs (5) symptoms to severe that they cause complete *inability to run*, (6) younger than 18 years of age.

Design outcomes

Primary

Measure	Time frame
The following primary outcomes will be assessed at baseline and post-treatment (12 weeks after baseline). - VISA-A score - Mechanical pain threshold - Self-perceived clinical progress (GROC) VISA-A and GROC will also be assessed every week throughout the study.	—

Secondary

Measure	Time frame
A web-based log will be developed in order to collect data on: - running exposure (hours/week, km/week, and times/week); - level of pain during running assessed with an 11-point NRS (0 to 10); - adherence to the assigned treatment (SMR or ECC); and - competing interventions (performance of other interventions alongside with the assigned treatment including medication). Data on these secondary outcomes will be collected every week throughout the study (12 weeks).	—

Measure

Time frame

A web-based log will be developed in order to collect data on: - running exposure (hours/week, km/week, and times/week); - level of pain during running assessed with an 11-point NRS (0 to 10); - adherence to the assigned treatment (SMR or ECC); and - competing interventions (performance of other interventions alongside with the assigned treatment including medication). Data on these secondary outcomes will be collected every week throughout the study (12 weeks).

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)